ClinVar Miner

Submissions for variant NM_000059.3(BRCA2):c.8805G>A (p.Met2935Ile) (rs730881568)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000160157 SCV000210484 uncertain significance not provided 2014-01-10 criteria provided, single submitter clinical testing This variant is denoted BRCA2 c.8805G>A at the cDNA level, p.Met2935Ile (M2935I) at the protein level, and results in the change of a Methionine to an Isoleucine (ATG>ATA). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. BRCA2 Met2935Ile was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a conservative substitution of one neutral non-polar amino acid for another, altering a position that is highly variable throughout evolution and is located in the DNA-binding domain (Borg 2010). In silico analyses predict this variant to have a benign effect on protein structure and function. The currently available evidence about this variant does not allow us to predict whether BRCA2 Met2935Ile is a pathogenic variant or benign variant, and it is therefore classified as having unknown significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.